These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8137478)

  • 21. Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
    Nishikawa H; Osaki Y; Kita R; Kimura T; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Saito S; Nasu A
    Int J Oncol; 2012 Sep; 41(3):903-9. PubMed ID: 22692851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
    Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
    Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.
    Beppu T; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Ogura S; Kasai C; Kusagawa S; Nojiri K; Yoneda M; Fuke H; Yamamoto N; Takei Y; Fujimori M; Hasegawa T; Yamanaka T; Uraki J; Kashima M; Takaki H; Nakatsuka A; Yamakado K; Takeda K
    Anticancer Res; 2012 Nov; 32(11):4923-30. PubMed ID: 23155261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.
    Ichida T; Kato M; Hayakawa A; Watanabe M; Igarashi K; Hata K; Doya Y; Miura M; Sato H; Asakura H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S51-4. PubMed ID: 1281045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma.
    Yasui M; Nonami T; Kurokawa T; Nakao A; Harada A; Hashimoto S; Kajikawa M; Hiraoka E; Takagi H
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S139-41. PubMed ID: 8137475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
    Iwamiya T; Sawada S; Morioka N; Tanigawa N; Kobayashi M; Nakamura K; Okuda Y; Hashimoto M; Ohta Y; Kawasaki H
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2213-7. PubMed ID: 1332626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
    Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of concentrated CDDP-lipiodol emulsion for hepatic arterial infusion therapy in patients with nonresectable hepatoma].
    Nakashima K; Iwao Y; Suzuki K; Tada I; Kim YI; Kobayashi M; Mori K; Takayama F; Takeyama M; Aikawa H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1731-5. PubMed ID: 2167645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
    Ikushima I; Higashi S; Seguchi K; Ishii A; Ota Y; Shima M; Kanemaru M; Hidaka Y
    Eur J Radiol; 2009 Jan; 69(1):114-9. PubMed ID: 17935921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
    Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intra-arterial infusion and chemo-embolization therapy for hepatocellular carcinoma using lipiodol and cisplatin].
    Kasugai H; Kojima J; Tatsuta M; Tanaka S; Okuda S; Sasaki Y; Imaoka S; Fujita M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Feb; 85(2):207-16. PubMed ID: 2455080
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
    Nagasue N; Yukaya H; Okamura J; Kuroda C; Kubo Y; Hirai K; Tanikawa K; Okita K; Ando K; Tamura K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2786-92. PubMed ID: 3019251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique.
    Higashi S; Shimizu M; Nakashima T; Iwata K; Uchiyama F; Tateno S; Tamura S; Setoguchi T
    Cancer; 1995 Mar; 75(6):1245-54. PubMed ID: 7882276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
    Ishibashi T; Okajima K; Isozaki H; Morita S; Nakata E; Nishimura J; Iga C; Amioka K; Tanimura M; Hara H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2778-81. PubMed ID: 2551222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.